Transforming Patient Mobility Assessment With Modus Health Stepwatch
At Modus Health, we accurately measure real-world walking quantity, intensity, and duration with our wearable, StepWatch. This information helps determine what treatments, therapies, and drugs improve mobility.
Numerous wearables track mobility, yet StepWatch stands out for maintaining its accuracy specifically in patients with slow or irregular walking patterns. StepWatch has been published in over 600 scientific journal articles where clinically relevant endpoints can be identified in over 40 patient conditions. With this advantage, we created specific products to fit into the flow of clinical trials, academic research, and clinical care.
![WorldBI Sponsor Blogs](assets/img/page/patient-mobility.webp)
Clinical Research Trial Software
Our clinical research trial apps (CR) are designed for pharmaceutical clinical trials. Participants are blinded to their data as it transfers to a secure cloud for transmission to the sponsor. Our team can help sponsors choose the strongest endpoints based on previously published research in over 40 patient conditions. In addition, our team supplies data cleaning and 24/7 support services. Our clinical research trial application is supporting clinical trials around the world in Europe, North America, Asia, Australia, and South America.
![WorldBI Sponsor Blogs](assets/img/page/research-trials.webp)
![WorldBI Sponsor Blogs](assets/img/page/care-software.webp)
Clinical Care Software
Our clinical care app (CC) is designed to increase walking during patient hospital stays and outpatient care. Increased daily steps, as measured with StepWatch, has resulted in improved patient outcomes including shorter length of stay, reduced risk of readmission, and further distances during the six-minute walk test (6MWT). Increased daily steps in the community, as measured with StepWatch, in people with Chronic Obstructive Pulmonary Disease (COPD) have resulted in reduced COPD-related hospitalization and acute exacerbations. By making walking progress transparent, the patient is more engaged in their recovery and health maintenance. Our CC software is currently operational in hospitals across Europe, the United States, and Australia.
Research Software
Our academic research app (RE) is used by universities to understand the impact of treatments, therapies, and drugs on real world mobility. This software does not have a cloud, making it a more economical choice for small studies and educational purposes. This software is the most flexible in terms of how you can setup StepWatch for recording different walking patterns.
![WorldBI Sponosor Blogs](assets/img/page/research-software.webp)
Conclusion
Modus Health’s StepWatch represents a significant advancement in patient mobility assessment. With its unparalleled accuracy, ease of use, and seamless integration, StepWatch is transforming how healthcare providers and researchers monitor and improve patient mobility. As the healthcare landscape continues to evolve, StepWatch will play a crucial role in enhancing patient outcomes and advancing medical research.
For more information about StepWatch and to request a demo, visit the Modus Health website.
About Digital Health AI Innovation Summit 2024
Join World BI for Digital Health AI Innovation Summit – a unique opportunity to connect with thought leaders from the pharma, healthcare, and medtech industries, while learning about the newest trends in digital health technologies.
This new conference provides you with industry recommendations, case studies, and the actionable insights you need to transform your own projects and strategically bring it to the next level through scientific discovery, collaborative research, medtech entrepreneurship, and pharma-tech partnerships.
Join us to learn from the best in the digital health industry, including clinicians, scientists, entrepreneurs, biomedical engineers, patient advocates, and top technology providers across the globe. And if that’s not enough, the conference will be held at the Boston Marriott Cambridge, Massachusetts.